TY - JOUR
T1 - How to select the most appropriate patient and lesion to be treated with a coronary bioresorbable vascular scaffold
AU - Costopoulos, Charis
AU - Latib, Azeem
AU - Colombo, Antonio
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2013/8
Y1 - 2013/8
N2 - Bioresorbable vascular scaffolds (BVS) are an exciting novel treatment for coronary artery disease (CAD) as their eventual resorption renders the artery free from a permanent metallic cage. Clinical trials regarding these novel devices have demonstrated promising results, although their use in this context has largely been restricted to simple lesions. More recently, BVS use has expanded to patients with more complex lesions including those with long diffuse disease, and results from several registries are awaited with regard to their efficacy in 'real-world' patients. Although any patient who requires percutaneous treatment for CAD could benefit from BVS implantation, there are certain cohorts of patients and lesions in whom BVS could be of particular benefit. In this review, we attempt to identify which patient and lesion cohort is most suitable for treatment with these novel devices.
AB - Bioresorbable vascular scaffolds (BVS) are an exciting novel treatment for coronary artery disease (CAD) as their eventual resorption renders the artery free from a permanent metallic cage. Clinical trials regarding these novel devices have demonstrated promising results, although their use in this context has largely been restricted to simple lesions. More recently, BVS use has expanded to patients with more complex lesions including those with long diffuse disease, and results from several registries are awaited with regard to their efficacy in 'real-world' patients. Although any patient who requires percutaneous treatment for CAD could benefit from BVS implantation, there are certain cohorts of patients and lesions in whom BVS could be of particular benefit. In this review, we attempt to identify which patient and lesion cohort is most suitable for treatment with these novel devices.
KW - Bioresorbable vascular scaffold
KW - Major adverse cardiac events
KW - Target lesion revascularisation
UR - http://www.scopus.com/inward/record.url?scp=84894048861&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84894048861&partnerID=8YFLogxK
U2 - 10.15420/icr.2013.8.2.90
DO - 10.15420/icr.2013.8.2.90
M3 - Article
AN - SCOPUS:84894048861
VL - 8
SP - 90
EP - 92
JO - Interventional Cardiology Review
JF - Interventional Cardiology Review
SN - 1756-1477
IS - 2
ER -